Juergen Wolf
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 3
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 4
- Co-authors
- Volker Diehl (3 shared papers)Michael J. Hallek (5 shared papers)Raymond Voltz (4 shared papers)Jan Gaertner (4 shared papers)Jan‐Peter Glossmann (3 shared papers)Michael E May (1 shared paper)Jeremy G. Franklin (1 shared paper)Andreas Engert (1 shared paper)
- Journals
- Journal of Thoracic Oncology (5 papers)Cancer Discovery (2 papers)Journal of Clinical Oncology (2 papers)Supportive Care in Cancer (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Juergen Wolf
36 papers receiving 4.8k citations
Juergen Wolf's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.8k
- Cancer Research 760
- Pathology and Forensic Medicine 515
- Molecular Biology 1.3k
Countries citing papers authored by Juergen Wolf
This map shows the geographic impact of Juergen Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Wolf more than expected).
Fields of papers citing papers by Juergen Wolf
This network shows the impact of papers produced by Juergen Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Wolf. The network helps show where Juergen Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Juergen Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer Hit paper breakdown → | 2014 | 1236 |
| 2 | First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study Hit paper breakdown → | 2017 | 954 |
| 3 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Hit paper breakdown → | 2018 | 496 |
| 4 | 2017 | 298 | |
| 5 | Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS -Mutant Advanced Non–Small Cell Lung Cancer Hit paper breakdown → | 2017 | 294 |
| 6 | 2018 | 221 | |
| 7 | 2018 | 157 | |
| 8 | 2015 | 149 | |
| 9 | 2019 | 134 | |
| 10 | 2020 | 129 | |
| 11 | 2003 | 126 | |
| 12 | 2020 | 105 | |
| 13 | 2003 | 91 | |
| 14 | 2005 | 86 | |
| 15 | 2011 | 61 | |
| 16 | 2005 | 60 | |
| 17 | 2020 | 51 | |
| 18 | 2019 | 45 | |
| 19 | 2011 | 37 | |
| 20 | Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors | 2014 | 34 |
About Juergen Wolf
Juergen Wolf is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 37 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Palliative Care and End-of-Life Issues (3 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (760 citations), Pathology and Forensic Medicine (515 citations) and Molecular Biology (1.3k citations). Juergen Wolf has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Diehl, Michael J. Hallek, Raymond Voltz, Jan Gaertner, Jan‐Peter Glossmann, Michael E May, Jeremy G. Franklin, Andreas Engert, Andreas Josting and Markus Sieber. Their work appears in journals such as Journal of Thoracic Oncology, Cancer Discovery, Journal of Clinical Oncology, Supportive Care in Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.